scorecardresearch
Add as a preferred source on Google
Saturday, February 21, 2026
TopicCureVac

Topic: CureVac

GlaxoSmithKline, CureVac team up to develop vaccines to tackle Covid variants

Suzi Ring -
The immunisations may be used to protect people who haven’t been inoculated or as booster shots if immunity from other vaccines wanes.

Covid vaccine contender CureVac BV shares soar 249% in US trading debut

Crystal Tse -
CureVac, based in Tubingen, Germany, said in June that it received regulatory approval to begin Phase 1 trials of its vaccine candidate. It said it expects the results in the fourth quarter.

On Camera

YourTurn

Opinion

Cautious optimism — India’s new relationship with Tarique Rahman’s Bangladesh

Sushant Sareen -
Both Bangladesh and India will have to work together to repair the damage done during the Yunus administration.

5 years of Ukraine war—why Delhi must de-hyphenate Moscow from the West

+TFP

India can sell its vision, but it can’t spectacle its way to AI power

Economy

In the West, there’s anxiety. In India, optimism—Rishi Sunak says India poised to be leader in AI

Vrinda Tulsian -
On Wednesday, the former UK Prime Minister Rishi Sunak was speaking in New Delhi at a Carnegie & Observer Research Foundation event on AI.

Defence

Embraer moves full throttle in pursuit of IAF contract, ties up with Hindalco after Adani

Snehesh Alex Philip -
IAF is firming up plans to revamp airlift capabilities with medium transport aircraft that will be assembled in India & serve as its main workhorse. Embraer is leading contender as of now.

National Interest

No country is ever fully sovereign. Cold War era taught India its real meaning

Shekhar Gupta -
India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.